Terms: = Ovarian cancer AND Ki-67 AND Treatment
148 results:
1. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast cancer: A Randomized Clinical Study.
Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
[TBL] [Abstract] [Full Text] [Related]
2. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.
Le Tran N; Wang Y; Bilandzic M; Stephens A; Nie G
Sci Rep; 2024 Mar; 14(1):7539. PubMed ID: 38553472
[TBL] [Abstract] [Full Text] [Related]
3. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
4. [Antitumor effects of redox-responsive nanoparticles containing platinum（Ⅳ）in ovarian cancer].
Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
[No Abstract] [Full Text] [Related]
5. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
Zhang M; Wang J; Guo Y; Yue H; Zhang L
J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063
[TBL] [Abstract] [Full Text] [Related]
6. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
Ran XM; Xiao H; Tang YX; Jin X; Tang X; Zhang J; Li H; Li YK; Tang ZZ
Sci Rep; 2023 Nov; 13(1):19474. PubMed ID: 37945610
[TBL] [Abstract] [Full Text] [Related]
7. FOXM1 Contributes to Chemotherapy Sensitivity in Cervical cancer by Regulating TTK.
Tang Q; Xu A; Yang Y; Zhang Y; Sun J
Discov Med; 2023 Jun; 35(176):208-220. PubMed ID: 37272088
[TBL] [Abstract] [Full Text] [Related]
8. Clinical characteristics and survival outcomes in patients with primary ovarian carcinoid: A historical cohort study.
Kong S; Sun J; Sui X; Zhang S; Qi Y; Ma Y; Li S
Acta Obstet Gynecol Scand; 2023 Jul; 102(7):935-941. PubMed ID: 37059424
[TBL] [Abstract] [Full Text] [Related]
9. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
10. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway.
Yu YH; Zhang HJ; Yang F; Xu L; Liu H
J Ethnopharmacol; 2023 Jun; 310():116311. PubMed ID: 36894110
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells.
Wang YJ; Tang L; Lu XH; Liu JT; Wang YY; Geng HX; Li XT; An Q
J Liposome Res; 2023 Jun; 33(2):197-213. PubMed ID: 36440599
[TBL] [Abstract] [Full Text] [Related]
12. Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling Pathway-Mediated Autophagy for Cisplatin-Resistant ovarian cancer Therapy.
Zhang M; Yue H; Huang X; Wang J; Li Z; Deng X
ACS Appl Mater Interfaces; 2022 Nov; 14(43):48502-48514. PubMed ID: 36261925
[TBL] [Abstract] [Full Text] [Related]
13. A Case of Primary Insular ovarian Carcinoid Tumor with Hyperandrogenism and Carcinoid Heart Disease.
Mansour S; Anaka MR; Al-Agha R
Am J Case Rep; 2022 Oct; 23():e937403. PubMed ID: 36181247
[TBL] [Abstract] [Full Text] [Related]
14. Hormonal, apoptotic, proliferative and inflammatory markers' expression in Desogestrel-treated women with ovarian endometriosis.
Matasariu DR; Lozneanu L; Dumitraşcu I; Grigore M; Cristofor AE; Mandici CE; Bujor IE; Ursache A; Brăila AD; Bauşic A; Micu R
Rom J Morphol Embryol; 2022; 63(1):137-144. PubMed ID: 36074677
[TBL] [Abstract] [Full Text] [Related]
15. [IL-1β inhibitor sensitizes to olaparib in homologous recombination deficiency proficient ovarian cancer cells].
Xu JF; Cen YX; Tang SS; Ren Y; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2022 Jul; 57(7):519-529. PubMed ID: 35902786
[No Abstract] [Full Text] [Related]
16. Carcinoid ovary with synchronous carcinoid tumour of the appendix: report of a rare occurrence with review of literature.
Baruah U; Tak A; Kakoti L; Barmon D
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35750423
[TBL] [Abstract] [Full Text] [Related]
17. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
[TBL] [Abstract] [Full Text] [Related]
18. Understanding the Correlation between Metabolic Regulator SIRT1 and Exosomes with CA-125 in ovarian cancer: A Clinicopathological Study.
Roy S; Das A; Vernekar M; Mandal S; Chatterjee N
Biomed Res Int; 2022; 2022():5346091. PubMed ID: 35496046
[TBL] [Abstract] [Full Text] [Related]
19. MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism.
Fang Y; Yu H; Zhou H
Biochem Biophys Res Commun; 2022 Apr; 598():47-54. PubMed ID: 35151203
[TBL] [Abstract] [Full Text] [Related]
20. Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells.
Harper AK; Wang X; Fan R; Kirsch Mangu T; Fletcher NM; Morris RT; Saed GM
Minerva Obstet Gynecol; 2023 Apr; 75(2):150-157. PubMed ID: 34825792
[TBL] [Abstract] [Full Text] [Related]
[Next]
